Literature DB >> 19661665

Experience with transverse preputial island flap for repair of hypospadias in Ile-Ife, Nigeria.

A O Sowande1, A O Olajide, A A Salako, F O Olajide, O Adejuyigbe, A O Talabi.   

Abstract

OBJECTIVE: To review our experience with the use of transverse preputial island flap in the repair of hypospadias in the paediatric surgical unit of our University Teaching Hospital, Nigeria. PATIENTS AND METHODS: We reviewed the cases of hypospadias managed by transverse preputial island flap repair over a ten year period (1996 and 2006) in the paediatric surgical unit of our institution. Data was retrieved from the case notes and analysed.
RESULTS: Fifty-one patients had hypospadias repair during the period, 22 of whom were by transverse preputial island flap repair. Hypospadisas were in penile shaft in 16 (72.7%), penoscrotal in 5 (22.7%) and perineal in 1 (4.55%). All the patients had intact prepuce at presentation and chordee was present in 18 (81.8%). The commonest complication was urethrocutaneous fistula in five patients, which closed spontaneously in three leaving 2 patients (9.1%) with persistent urethrocutaneous fistular.
CONCLUSION: Transverse preputial island flap urethroplasty remains a viable option in the management of hypospadias especially when the meatal opening is proximal, with associated chordee limiting the options in the repair.

Entities:  

Mesh:

Year:  2009        PMID: 19661665     DOI: 10.4103/0189-6725.48575

Source DB:  PubMed          Journal:  Afr J Paediatr Surg        ISSN: 0974-5998


  2 in total

1.  EXPERIENCE WITH MANAGING CHILDHOOD URETHROCUTANEOUS FISTULA AT IBADAN.

Authors:  A O Takure; S A Adebayo; P T Sotunbi; E O Olapade-Olaopa; L I Okeke; O B Shittu
Journal:  J West Afr Coll Surg       Date:  2017 Jul-Sep

2.  Hypospadias repair and outcome in Abuja, Nigeria: A 5-year single-centre experience.

Authors:  Oseremen Inokhoife Aisuodionoe-Shadrach; Terkaa Atim; Bolarinwa Sefiu Eniola; Alexander Akogwu Ohemu
Journal:  Afr J Paediatr Surg       Date:  2015 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.